
Fighting pharma power since 2010 at @Public_Citizen. We work around the world to make sure people have access to lifesaving medicines. RTs =/= Endorsements.
Washington, D.C.
Joined November 2011
- Tweets4.6K
- Following1.3K
- Followers2.1K
- Likes2.5K
Access to Meds retweeted
Trump exempted nearly all pharma companies from one of his plans to cut drug prices in Medicare so expected savings dropped from nearly $12 billion to about $440 million.
citizen.org/news/finalized-g…
Read Public Citizen’s analysis of Trump’s secretive deals with pharma: citizen.org/article/public-c…
For months, Trump has touted his drug-price deals — saying his work should be enough for the GOP to win the midterms.
But Trump and his deputies have declined to release the deals' actual text.
@Public_Citizen sued to get two deals thru FOIA and shared them with The Post.
Access to Meds retweeted
Trump is expected to announce more MFN deals today. It has been almost a year since he first started rolling out these deals and he has almost nothing to show for it. New deals are a distraction from Trump's failed plan to lower U.S. drug prices.
citizen.org/news/trumps-drug…
Access to Meds retweeted
The Trump administration is working to cut global health funding to developing nations by tens of billions of dollars by 2030, according to a new analysis of the secretive agreements U.S. officials have pursued with more than a dozen governments to date. wapo.st/4i4nbIa
Access to Meds retweeted
New @Public_Citizen @PCMedsAccess and @PIH
analysis finds Trump's global health funding cuts appear to reduce U.S. spending on global health initiatives to less than half of Washington’s output in 2024.
washingtonpost.com/national-…
Public Citizen and @PIH warn of cuts under Trump’s global health deals and a widening gap between Congressional funding and planned support for countries: citizen.org/news/trumps-agre….
PC’s FOIA requests also revealed 6 new health agreement texts: citizen.org/article/u-s-bila…
37
Access to Meds retweeted
If the consumer drug pricing index has seen unprecedented drops, Trump should get almost none of the credit. Few of Trump’s MFN policies to reduce drug prices have even taken effect, nor would many of his policies be trackable in the index.
citizen.org/article/four-rea…
New Report: Medicare Quietly Gifted AbbVie’s Blockbuster Drug Seven Extra Years Before Price Negotiations
Read it here:
citizen.org/news/medicare-qu…
New @Public_Citizen investigation: A little-known change to Medicare Rx price negotiation rules may cost taxpayers billions and generate a windfall for AbbVie by excluding its pancreatic insufficiency drug Creon from negotiation for an extra seven years.
citizen.org/article/medicare…
Access to Meds retweeted
Negotiating drug prices at launch would ensure that patients and health programs get fair prices on prescription drugs at the outset, instead of first facing nearly a decade or longer of excessive prices set to maximize revenues. | Forefront
@SarahKarlin | @Public_Citizen
healthaffairs.org/do/10.1377…
New article out today in Health Affairs Forefront by our research director @SarahKarlin : Why Medicare Must Negotiate Drug Prices At Launch citizen.org/news/medicare-sh…
Access to Meds retweeted
4 out of 10 Americans ration the drugs they need because they cannot afford them.
Big Pharma's price gauging is out of control.
As our co-president @Rob_Weissman notes: the government grants Big Pharma their monopolies, and it's time to stop!
Thanks @fastlerner and Anna Maria Barry-Jester for speaking with us about the Trump admin’s unprecedented demands for data access in exchange for global health funding.
Our new analysis of the few publicly-available health agreements:
citizen.org/wp-content/uploa…
The U.S. says Africans’ health data shared under humanitarian aid deals will be aggregated and anonymized, but the State Department’s demands have sparked an outcry in Africa and raised concerns that the data could be misused or exploited.
propublica.org/article/trump…
Access to Meds retweeted
Replying to @Winnie_Byanyima @UNAIDS @AFRAVIH @UNAIDS_WCA @GhanaUNAIDS @UNAIDS_CI @UnaidsGambia @ONUSIDA_RCA @HIVpxresearch @UNAIDS_ESA @UNAIDS_AU_ECA @UNAIDS_EECA @UNAIDS_AP @UnaidsLac @UNAIDSCaribbean @UNAIDSBrasil @UNAIDS_NewYork
We cannot continue negotiating access to medicines and health technology product by product. We need structural change:
✅ Rethinking intellectual property rules
✅ Expanding regional manufacturing
✅ Embedding equity into innovation from the start
Otherwise, science will continue to move faster than access — and inequality will persist.
#AFRAVIH2026 #endAIDS
Access to Meds retweeted
Replying to @Winnie_Byanyima @UNAIDS @AFRAVIH @UNAIDS_WCA @GhanaUNAIDS @UNAIDS_CI @UnaidsGambia @ONUSIDA_RCA @HIVpxresearch @UNAIDS_ESA @UNAIDS_AU_ECA @UNAIDS_EECA @UNAIDS_AP @UnaidsLac @UNAIDSCaribbean @UNAIDSBrasil
We must confront inequality in access to life-saving science.
Take lenacapavir: current market price is over $28,000 per person per year. However, sold at scale it could be as low as $40 — potentially falling to $25.
After sustained pressure, we secured generic agreements at that price. But with only six companies licensed globally — none in Sub-Saharan Africa, and key countries are excluded — scale-up will take years.
Which means 2 million people may receive it, when we actually need 20 million on PrEP, including 13 million on long-acting options.
#AFRAVIH2026 #endAIDS
Access to Meds retweeted
Holding HIV treatment hostage to extract mineral deals is indefensible. More than a million Zambians rely on this aid.
This administration always finds a new low.
nytimes.com/2026/03/16/healt…
Transparency and obligations that support broad access to medical tools are non-negotiable in pandemic prevention, preparedness and response.
Public Citizen, @Saludporderecho, and @HAImedicines are calling on the EU and others to step up: saludporderecho.org/mpox-y-a…
43
Access to Meds retweeted
Fortunately, every country has the right to override the patent monopoly and authorize generics, if Big Pharma moves this way.
Not selling your patented product is called a working failure. It’s a classic use case for a compulsory license.
Access to Meds retweeted
We wrote Pfizer CEO Albert Bourla to ask where he gets off threatening to withhold drugs from countries that need them.
“ Americans pay too much for drugs. But that is not France’s fault, or responsibility. It is yours.”
Americans aren’t going bankrupt from cancer b/c Europeans get the same meds for less. They are going broke so pharma CEOs can get their multi-million $ paydays, & they are going broke so pharma can enrich shareholders.
citizen.org/news/pfizer-cann…
Access to Meds retweeted
Americans aren’t going bankrupt from cancer b/c Europeans get the same meds for less. They are going broke so pharma CEOs can get their multi-million $ paydays, & they are going broke so pharma can enrich shareholders.
citizen.org/news/pfizer-cann…













